265 related articles for article (PubMed ID: 33610554)
1. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
3. Glycomic analyses of mouse models of congenital muscular dystrophy.
Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
[TBL] [Abstract][Full Text] [Related]
4. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects].
Endo T
Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
6. Mammalian
Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
[TBL] [Abstract][Full Text] [Related]
7. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
8. Protein
Halmo SM; Singh D; Patel S; Wang S; Edlin M; Boons GJ; Moremen KW; Live D; Wells L
J Biol Chem; 2017 Feb; 292(6):2101-2109. PubMed ID: 27932460
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease.
Manya H; Sakai K; Kobayashi K; Taniguchi K; Kawakita M; Toda T; Endo T
Biochem Biophys Res Commun; 2003 Jun; 306(1):93-7. PubMed ID: 12788071
[TBL] [Abstract][Full Text] [Related]
12. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion.
Lommel M; Winterhalter PR; Willer T; Dahlhoff M; Schneider MR; Bartels MF; Renner-Müller I; Ruppert T; Wolf E; Strahl S
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21024-9. PubMed ID: 24297939
[TBL] [Abstract][Full Text] [Related]
13. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
Voglmeir J; Kaloo S; Laurent N; Meloni MM; Bohlmann L; Wilson IB; Flitsch SL
Biochem J; 2011 Jun; 436(2):447-55. PubMed ID: 21361872
[TBL] [Abstract][Full Text] [Related]
14. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).
Liu J; Ball SL; Yang Y; Mei P; Zhang L; Shi H; Kaminski HJ; Lemmon VP; Hu H
Mech Dev; 2006 Mar; 123(3):228-40. PubMed ID: 16458488
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
[TBL] [Abstract][Full Text] [Related]
16. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.
Yoshida A; Kobayashi K; Manya H; Taniguchi K; Kano H; Mizuno M; Inazu T; Mitsuhashi H; Takahashi S; Takeuchi M; Herrmann R; Straub V; Talim B; Voit T; Topaloglu H; Toda T; Endo T
Dev Cell; 2001 Nov; 1(5):717-24. PubMed ID: 11709191
[TBL] [Abstract][Full Text] [Related]
17. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
[TBL] [Abstract][Full Text] [Related]
19. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
[TBL] [Abstract][Full Text] [Related]
20. Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.
Hehr U; Uyanik G; Gross C; Walter MC; Bohring A; Cohen M; Oehl-Jaschkowitz B; Bird LM; Shamdeen GM; Bogdahn U; Schuierer G; Topaloglu H; Aigner L; Lochmüller H; Winkler J
Neurogenetics; 2007 Nov; 8(4):279-88. PubMed ID: 17906881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
